"We were hesitant about the Bangladesh market due to payment concerns. Mammtech secured 100% LC payments for every single shipment. We now export $2M annually."
We're Mammtech Corporation โ Bangladesh's trusted DGDA-registered pharmaceutical indenting agent. We connect global API & raw material manufacturers with 200+ verified Bangladesh pharma companies who collectively import over $1.3 billion in APIs annually. Expert regulatory support, secure LC/DA payments, WHO-GMP compliance guidance.
Opportunity: Bangladesh has 300+ pharma companies producing medicines for 170M people, yet imports 90%+ of required APIs — your raw materials are in high demand.
Submit your product offering below, and our team will connect you with qualified buyers within 48 hours
A structured, legally compliant pathway from supplier onboarding to continuous orders.
The manufacturer or supplier (the foreign principal) issues a formal Agency Agreement (Agencies Deed) appointing Mammtech as their exclusive, licensed indenting agent in Bangladesh. Mammtech then registers this agreement with the CCI&E (Chief Controller of Imports & Exports) to obtain the official Indenting Registration Certificate ๏ฟฝ a government-recognised legal credential authorising Mammtech to represent, negotiate, and facilitate all commercial transactions on behalf of the foreign principal with DGDA-licensed Bangladesh pharma manufacturers.
Mammtech identifies Bangladesh pharma manufacturers with active R&D requirements matching your product portfolio. You supply precisely specified samples ๏ฟฝ quantity, grade (IP/USP/BP), packing, and documentation (COA, MSDS, Stability Report) ๏ฟฝ as per the manufacturer's technical requirement sheet.
The manufacturer's internal QC laboratory conducts rigorous analysis of your sample against their in-house specifications. Concurrently, Mammtech facilitates commercial price negotiation ๏ฟฝ targeting a price point acceptable to both parties based on current Bangladesh market benchmarks.
Upon mutual acceptance of quality and price, Mammtech issues a Proforma Invoice (PI) and coordinates the manufacturer's bank to open an irrevocable, at-sight Letter of Credit (LC) in favour of the supplier. This ensures 100% payment security before shipment.
A successful first order is the beginning, not the end. Mammtech works to consolidate your position as the preferred supplier for that molecule across multiple Bangladesh manufacturers ๏ฟฝ driving repeat, scheduled orders and building you a stable, recurring revenue stream in one of Asia's fastest-growing pharma markets.
Join 50+ international suppliers already working with us
Start Your Journey TodayStrategic insights from active DGDA import data to help you target the right demand
Years of Experience
Pharma Company Clients
Product Variants
International Suppliers
Common questions from international suppliers about the Bangladesh market
We work exclusively with buyer companies that facilitate 100% Irrevocable Letters of Credit (LC) through top-tier banks. This ensures payment is guaranteed upon shipment document presentation, eliminating credit risk.
All pharmaceutical imports require Source Validation and Block List approval from the Directorate General of Drug Administration (DGDA). Our regulatory team manages this entire process for you, submitting your GMP/CoPP/DMF documents to obtain necessary permissions quickly.
No. As your legal Indenting Partner, Mammtech acts as your representative on the ground. We handle client visits, sample delivery, regulatory follow-up, and tender participation on your behalf.
Currently, there is high demand for Cardiovascular, Diabetic, and Antibiotic APIs (like Metformin, Ameropenem) as well as excipients like MCC and Lactose. Check our High-Demand Products section for specific active inquiries.
Ready to introduce your APIs to Bangladesh? Contact our procurement team today.